SymPhysis Medical
Endowave is a technology driven company focused on delivering the best in class flexible ablation catheter system.
SymPhysis Medical was founded by Tim Jones and Dr. Michelle Tierney after completing the BioInnovate Fellowship in NUIG, which is a specialist medical device innovation programme affiliated with the Stanford BioDesign programme in the US.
The company is developing a disruptive technology to address ‘fluid on the lung’ or malignant pleural effusion, which is a common complication of late-stage cancers.
The new technology is designed to be less invasive, more effective and more user-friendly than current devices on the market, while also reducing hospital costs.
The driving force behind SymPhysis Medical is an unwavering commitment to provide independence and improved quality of life for people requiring palliative care.